I'm a bit less bullish on these results. UK subscriber growth is slowing (+17% vs +32% y-o-y), and they are not really making any progress in North America (+18% vs +24% off a very small base). ANZ was impressive, but these are becoming more mature markets with less upside.
Clearly COVID-19 hit the SME base hard, but could also have been a driver for firms to move to cloud accounting. To justify the valuation, XRO has to win in North America. The trends don't look favourable.
These kinds of results were baked into many of the higher valuation. Yesterday, I assessed risk/reward as unfavourable and have exited after holding for 4 years.
If you roll these growth rates forward 5 years, when earnings become material, you get a P/E that is way too high given the continuing growth. (I say this recognising that P/E is not a meaningful metric at this time for XRO.)
Love the company, love the product and would buy again at the right price. Given the macro picture on growth and tech, I'll wait for $110 to re-enter.
GLTAH.
- Forums
- ASX - By Stock
- XRO
- News: XRO Xero Reports FY Net Profit Of NZ$19.8 Mln
News: XRO Xero Reports FY Net Profit Of NZ$19.8 Mln, page-6
-
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add XRO (ASX) to my watchlist
(20min delay)
|
|||||
Last
$147.65 |
Change
-0.750(0.51%) |
Mkt cap ! $22.55B |
Open | High | Low | Value | Volume |
$148.01 | $148.39 | $146.33 | $33.70M | 228.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1066 | $147.21 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$147.68 | 41 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1066 | 147.210 |
1 | 2 | 146.050 |
2 | 83 | 146.000 |
1 | 240 | 145.760 |
1 | 140 | 145.710 |
Price($) | Vol. | No. |
---|---|---|
148.000 | 435 | 2 |
148.100 | 153 | 1 |
148.600 | 150 | 1 |
149.000 | 50 | 1 |
149.290 | 826 | 1 |
Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
Featured News
XRO (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online